Prenetics

About Prenetics

Founded in 2014, Prenetics is a major global diagnostic and genetic testing company with the mission to bring health closer to millions of people globally and decentralize healthcare by making the three pillars - prevention, diagnostics, and personalized care comprehensive, accessible to anyone, at any time and anywhere. Prenetics is led by a visionary entrepreneur, Danny Yeung, with a team of over 700 employees and operations across 9 locations, including the United Kingdom, Hong Kong, India, South Africa, and southeast Asia. Prenetics develops consumer genetic testing and early colorectal cancer screening; provides COVID-19 testing, rapid point of care at-home diagnostic testing, and medical genetic testing. Most recently, Prenetics made international headlines to become the first Unicorn in Hong Kong to publicly list on the Nasdaq via merger with 2021 Adrian Cheng's Artisan Acquisition Corp, valuing Prenetics at approximately US $1.7b.